Captopril and Tolbutamide: Interaction Details
- Tolbutamide
- Orinase
- Captopril
- Capoten
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Captopril and Tolbutamide interaction:
Tolbutamide
- Orinase
We don't have a drug information page for Tolbutamide yet. Have a question about Tolbutamide? Ask a pharmacist, free →
What Happens When You Take Captopril With Tolbutamide
What can happen when they are taken together (rated Moderate)
An increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
The risk of hypoglycemia may rise when antidiabetic agents are given together with .123 Where combined therapy cannot be avoided, blood glucose should be checked more often, not only while the ACE inhibitor is being taken but also once it has been discontinued.4
Adjusting the insulin dose may likewise prove necessary.12 According to findings from a self-controlled case series, taking insulin secretagogues alongside ACE inhibitors does not appear to be linked to higher rates of serious hypoglycemia, although glimepiride may be an exception.5
The Captopril and Tolbutamide Interaction, Explained
Tolbutamide (Orinase) lowers blood sugar by helping your pancreas release more insulin. Captopril (Capoten) is a blood pressure medicine. In some people, captopril may make the body a bit more sensitive to insulin, so together they could push blood sugar lower than expected.
The good news: this concern is mostly theoretical, and a large study did not show more serious low blood sugar with this type of combination. Still, know the signs of low sugar, like shakiness, sweating, confusion, or a fast heartbeat. Keep taking both as prescribed. Your care team can manage this by checking your sugars more often and adjusting your diabetes dose if needed.
Effect: Possible with captopril plus tolbutamide (sulfonylurea). Mechanism unknown; proposed contributors include -mediated increases in insulin sensitivity (bradykinin accumulation, improved peripheral glucose uptake). Not a -mediated PK interaction; no expected change in tolbutamide /.
Evidence: Theoretical; onset unspecified. A self-controlled case series found no increase in serious hypoglycemia with ACE inhibitors plus insulin secretagogues (possible exception: glimepiride).
- Increase blood glucose monitoring when captopril is started, during therapy, and after it is withdrawn.
- Individualize the antidiabetic regimen based on glucose readings.
- Counsel patients on hypoglycemia recognition and treatment.
See the 5 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Captopril and Tolbutamide Interact
The likely mechanism
Unknown
“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.
When two medicines can each cause the same effect, here changes in blood sugar, taking them together can add to it. That is often the reason for an interaction like this one, though the sources do not confirm it for this pair.
How to Manage the Captopril and Tolbutamide Interaction
This combination is commonly used, and your care team can manage it with a little extra attention.
- What your team may do: monitor your blood sugar more closely when captopril is started, while you take it, and if it is ever stopped. Your diabetes medicine dose may need to be adjusted and individualized by your care team.
- What you can do: keep taking both medicines as prescribed, check your blood sugar as directed, and learn the signs of low blood sugar.
- Tell your pharmacist or prescriber if you notice shakiness, sweating, confusion, or frequent low readings.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Captopril or Tolbutamide need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Angiotensin-converting enzyme inhibitors used concomitantly with insulin secretagogues and the risk of serious hypoglycemia
A self-controlled case series examined Medicare claims data from 5 states covering 1999 to 2011 to evaluate of with insulin secretagogues (glimepiride, glipizide, glyburide, nateglinide, and repaglinide) or with metformin, which served as a negative control. The measured outcome was presentation to a hospital for serious .
Over the observation period, the numbers of serious hypoglycemic events were 8159 for glimepiride, 14,353 for glipizide, 11,129 for glyburide, 1595 for nateglinide, 2901 for repaglinide, and 32,639 for metformin. After adjustment for confounders, the rate ratio (RR) showed no significant elevation with glipizide, glyburide, repaglinide, or metformin.
However, it was slightly elevated with glimepiride (RR, 1.23; 95% CI, 1.11 to 1.37) and slightly reduced with nateglinide (RR, 0.73; 95% CI, 0.56 to 0.96). Apart from glimepiride, these findings suggest that combined use of an ACE inhibitor and insulin secretagogues was not associated with a higher risk of serious hypoglycemia.5
Captopril and Tolbutamide: Common Questions
How serious is the Captopril and Tolbutamide interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How is the Captopril and Tolbutamide interaction managed?
This combination is commonly used, and your care team can manage it with a little extra attention. What your team may do: monitor your blood sugar more closely when captopril is started, while you take it, and if it is ever stopped. Your diabetes medicine dose may need to be adjusted and individualized by your care team. What you can do: keep taking both medicines as prescribed, check your blood s… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Captopril and Tolbutamide Interaction
Ask in your own words about taking Captopril and Tolbutamide together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (5)
- Product Information: TOUJEO(R) subcutaneous injection, insulin glargine subcutaneous injection. sanofi-aventis (per manufacturer), Bridgewater, NJ, 2015. DailyMed
- Product Information: AFREZZA(R) oral inhalation powder, insulin human oral inhalation powder. MannKind Corporation(TM) (per manufacturer), Danbury, CT, 2014. DailyMed
- Product Information: Zestril(R) oral tablets, lisinopril oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2014. DailyMed
- Product Information: AMARYL(R) oral tablets, glimepiride oral tablets. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
- Hee Nam Y, Brensinger CM, Bilker WB, et al: Angiotensin-converting enzyme inhibitors used concomitantly with insulin secretagogues and the risk of serious hypoglycemia. Clin Pharmacol Ther 2022; 111(1):218-226. PubMed
Other Serious Interactions of Captopril and Tolbutamide
Also serious with Tolbutamide
Also serious with Captopril
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Tolbutamide
- Activated CharcoalMajor
- Siberian CockleburMajor
- ChromiumModerate
- GingerModerate
- TurmericModerate
- InositolModerate
- AshwagandhaModerate
- Black PepperModerate
- + 299 more
With Captopril
- Activated CharcoalMajor
- American HelleboreMajor
- American MistletoeMajor
- AsarabaccaMajor
- Siberian CockleburMajor
- TyramineMajor
- Vitamin B6Moderate
- SodiumModerate
- + 158 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring. This interaction.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.